跳到主要內容

臺灣博碩士論文加值系統

(216.73.216.176) 您好!臺灣時間:2025/09/07 19:49
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:林蘭砡
研究生(外文):Lin, Lan-Chi
論文名稱:普洱茶降血脂之作用
論文名稱(外文):THe Hypolipidemic Effects of Pu-Erh tea
指導教授:孫璐西孫璐西引用關係蕭明熙蕭明熙引用關係---
指導教授(外文):Lucy Sun HwangMing-Shi Shiao
學位類別:碩士
校院名稱:國立臺灣大學
系所名稱:食品科技研究所
學門:農業科學學門
學類:食品科學類
論文種類:學術論文
論文出版年:1997
畢業學年度:85
語文別:中文
論文頁數:118
中文關鍵詞:普洱茶降血脂膽固醇
外文關鍵詞:Pu-Erh teaHypolipidemicCholesterol
相關次數:
  • 被引用被引用:9
  • 點閱點閱:3169
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:5
普洱茶降血脂之作用
國立台灣大學食品科技研究所
林蘭砡
摘要
普洱茶產於中國大陸雲南省,近年來在台灣也有越來越多人飲用。普洱茶是發酵茶,
造成的生理作用的活性成份可能來自茶種本身,也可能來自於微生物(如:Aspergillus
屬真菌)所產生的次級代謝物及茶中成份經生物轉換後的產物。曾有報導普洱茶可降低
雌性Wistar大白鼠血漿膽固醇及三酸甘油酯,並促進腎上腺誘導的脂解作用,推論普洱
茶可改善高血脂症及肥胖的現象。本研究之目的在評估普洱茶水萃出物於體外對膽固醇
生合成之抑制作用及在活體動物是否有降血脂之效果。在體外系統,採人類肝癌細胞株
(HepG2)為模式,並使用降膽固醇藥物lovastatin為正控制組,配合
放射性同位素前趨物([2-3H]acetate及R-[2-14C]mevalonic acid ) 之標示,以評估普
洱茶水萃出物可否抑制膽固醇生合成。動物試驗則選用雄性倉鼠及雄性Spague-Dawley
大白鼠,以評估普洱茶水萃出物可否抑制動物對外源性膽固醇吸收及阻斷腸肝循環,並
因而造成降血脂之效果。
體外試驗結果顯示: 40 mg/mL普洱茶水萃出物可減少56% 之膽固醇生合成,是在
mevalonate產生之前抑制(與lovastatin類似)。在動物試驗中,普洱茶亦有抑制膽固醇
合成之效果。以倉鼠為動物模式的試驗結果發現:以含高膽固醇飼料(1 % )動物的表現
為比對基礎,另添加1 %、1.5% 及2% 普洱茶水萃出物可降低動物肝臟中膽固醇含量及
血漿中三酸甘油酯、游離脂肪酸、膽固醇。在兩種動物模式中皆觀察到血中游離脂肪酸
降低,脂肪組織中三酸甘油酯合成增加。餵食普洱茶水萃出物的雄性倉鼠及雄性Spague-
Dawley大白鼠其糞便中膽固醇排出量亦顯著增加(p<0.05)。
本研究可得以下結論:普洱茶可以降低血漿膽固醇、三酸甘油酯及游離脂肪酸,減少膽
固醇性脂肪肝現象及增加糞便中膽固醇的排出。亦可輕微地抑制肝臟膽固醇生合成。

The Hypolipidemic Effects of Pu-Erh Tea
Lan-Chi, Lin.
Graduate Institute of Food Science and Technology, National Taiwan University,
Taipei, Taiwan, R.O.C.
Abstract
Pu-Erh tea is a fermented tea produced in the Yunan district in China.
Recently, this tea has also gained popularity in Taiwan. In Pu-Erh tea,
the bioactive ingredients can be originated from the tea leaves and their
transformed products by the endogenous enzymes. Metabolites derived from
the fermentation microorganisms such as Aspergillus, and biotransformation
products originally derived from tea may also contribute to the potential
biological activities of Pu-Erh tea. A previous study has indicated that
Pu-Erh tea reduces plasma cholesterol and triacylglycerol in female Wistar
rats. Meanwhile, the adrenalin-induced lipolysis is also stimulated, These
findings suggest that uptake of Pu-Erh tea may ameliorate hypolipidemia and
obiesty.
In this study, the potential of an aqueous extract of Pu-Erh tea (PET) on
cholesterol biosynthesis in vitro and lipid metabolism in vivo were elucidated
With lovastatin as a positive control, the incorporation of 〔2-3H〕acetate
and R-〔2-14C〕mevalonic acid into cholesterol by the cultured human hepotoma
cells (HepG2) was chosen as the in vitro model to elucidate the potential of
PET to inhibite cholesterol synthesis. In animal study, male hamsters and
male Spsgue-Dawley rats fed with cholesterol (1.0 %,
w/w) were chosen as animal models to elucidate the potential of PET to inhibit
hepatic cholesterol synthesis, intestinal cholesterol absorption, and
enetrohepatic circulation of bile acids.
In vitro syudy showed that PET reduced cholesterol biosynthesis significantly
(40 mg/mL PET showed 56 % inhibition) with the action mechanism of PET being
similar to that of lovastatin (pre-mevalonate inhibition). In animal models,
the results showed that PET inhibited cholesterol biosynthesis when compared
to the control group. It is intresting because lovastatin is a product of
Aspergillus and Aspergillus has often been found in the preparation of Pu-Erh
tea. PET supplemention also reduced hepatic cholesterol
content and the levels of serum cholesterol ,TG and FFA (p<0.05).
The reduction of serum FFA and elevation of incorporation of isotope labelled
acetate into TG in adipose tissue of hamsters suggested that PET stimulated
insulin sensitivity. The fecal cholesterol secretion was increased in hamsters
and rats fed with 1%, 1.5% and 2% PET. Cholesterol absorption in the intestine
is decreased by reducing the solubility of cholesterol in mixed micelles. The
finding that PET contained catechins further supported the observations
in these two animal models.
In comlusion, PET reduced liver cholesterol content and serum levels of
cholesterol, TG, FFA. The fecal cholesterol contents were increased.
Meanwhile, PET had the effect to inhibit cholesterol biosynthesis in vitro
and in vivo.

QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top